Investing Profile

James Healy

InvestorVC

Managing Partner at Sofinnova Investments

sofinnova.com/team/james-heal...Menlo Park, California
Photo of James Healy, Managing Partner at Sofinnova Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Sofinnova Investments Managing Partner
$100K - $5.0M
$1.5M
18
CompanyStageDateRound SizeTotal Raised
CinCor Pharma
Series BOct 2021$140M
Series AMay 2019$50M
$190M
Co-investors: David Allison (5am Ventures), Maina Bhaman (Soffinova Partners)
Karuna Therapeutics
Series BMar 2019$68M
$110M
Co-investors: Robert Nelsen (ARCH Venture Partners), Steve Paul (Third Rock Ventures), Heather Preston (Pivotal bioVenture Partners)
Edge Therapeutics
Series CApr 2015$56M
$56M
Co-investors: Anders Hove (Acorn Bioventures)
Natera
Series FApr 2015$56M
$160M
Co-investors: Roelof Botha (Sequoia Capital), Brian Singerman (Founders Fund), Ravi Mhatre (Lightspeed Venture Partners), Matthew Rizzo (OrbiMed), Andrew Chung (1955 Capital)
NuCana BioMed
Series BApr 2014$57M
$140M
Co-investors: Bali Muralidhar (Abingworth)
NuCana
Series BApr 2014$57M
$57M
ObsEva
Series AAug 2013C32M
CHF92M
Co-investors: Ed Mathers (New Enterprise Associates (NEA))
Auris Medical
Series CApr 2013C47M
CHF47M
Co-investors: Antoine Papiernik Papiernik (Soffinova Partners)